Clin Mol Hepatol.
2024 Apr;30(2):287-290. 10.3350/cmh.2024.0136.
Correspondence on Editorial regarding “Identification of signature gene set as highly accurate determination of MASLD progression”
- Affiliations
-
- 1Laboratory of Biomedical Genomics, Department of Biological Sciences, Sookmyung Women’s University, Seoul, Korea
- 2Molecular Medicine Lab, Department of Biological Sciences, Sookmyung Women’s University, Seoul, Korea
- 3Division of Rare Cancer, Research Institute, National Cancer Center, Goyang, Korea
- 4Research Institute of Women’s Health, Sookmyung Women’s University, Seoul, Korea
- KMID: 2554440
- DOI: http://doi.org/10.3350/cmh.2024.0136
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Identification of signature gene set as highly accurate determination of metabolic dysfunction-associated steatotic liver disease progression
- Bioinformatic identification of prognostic signature defined by copy number alteration and expression of CCNE1 in non-muscle invasive bladder cancer
- Thyroid Hormone-Mediated Selective Autophagy and Its Implications in Countering Metabolic Dysfunction-Associated Steatotic Liver Disease
- A gene expression signature of FOXM1 predicts the prognosis of hepatocellular carcinoma
- Changing from NAFLD to MASLD: Prevalence and progression of ASCVD risk are similar between NAFLD and MASLD in Asia
